Recombinant Influenza A virus Non-structural protein 1 (NS)

中文名稱：

Recombinant Influenza A virus Non-structural protein 1(NS)
貨號(hào)：

CSB-YP365961IFZ
說明書：

MSDS Datasheet
規(guī)格：
來源：

Yeast
其他：

中文名稱：

Recombinant Influenza A virus Non-structural protein 1(NS)
貨號(hào)：

CSB-EP365961IFZ
說明書：

MSDS Datasheet
規(guī)格：
來源：

E.coli
其他：

中文名稱：

Recombinant Influenza A virus Non-structural protein 1(NS)
貨號(hào)：

CSB-EP365961IFZ-B
說明書：

MSDS Datasheet
規(guī)格：
來源：

E.coli
共軛：

Avi-tag Biotinylated
E. coli biotin ligase (BirA) is highly specific in covalently attaching biotin to the 15 amino acid AviTag peptide. This recombinant protein was biotinylated in vivo by AviTag-BirA technology, which method is BriA catalyzes amide linkage between the biotin and the specific lysine of the AviTag.
其他：

中文名稱：

Recombinant Influenza A virus Non-structural protein 1(NS)
貨號(hào)：

CSB-BP365961IFZ
說明書：

MSDS Datasheet
規(guī)格：
來源：

Baculovirus
其他：

中文名稱：

Recombinant Influenza A virus Non-structural protein 1(NS)
貨號(hào)：

CSB-MP365961IFZ
說明書：

MSDS Datasheet
規(guī)格：
來源：

Mammalian cell
其他：

產(chǎn)品詳情
產(chǎn)品評(píng)價(jià)
靶點(diǎn)詳情

產(chǎn)品詳情

純度：

>85% (SDS-PAGE)
基因名：

NS
Uniprot No.：

P03496
別名：

NS; Non-structural protein 1; NS1; NS1A
種屬：

Influenza A virus (strain A/Puerto Rico/8/1934 H1N1)
蛋白長(zhǎng)度：

full length protein
表達(dá)區(qū)域：

1-230
氨基酸序列

MDPNTVSSFQ VDCFLWHVRK RVADQELGDA PFLDRLRRDQ KSLRGRGSTL GLDIETATRA GKQIVERILK EESDEALKMT MASVPASRYL TDMTLEEMSR DWSMLIPKQK VAGPLCIRMD QAIMDKNIIL KANFSVIFDR LETLILLRAF TEEGAIVGEI SPLPSLPGHT AEDVKNAVGV LIGGLEWNDN TVRVSETLQR FAWRSSNENG RPPLTPKQKR EMAGTIRSEV
蛋白標(biāo)簽：

Tag?type?will?be?determined?during?the?manufacturing?process.

The tag type will be determined during production process. If you have specified tag type, please tell us and we will develop the specified tag preferentially.
產(chǎn)品提供形式：

Lyophilized powder Warning: in_array() expects parameter 2 to be array, null given in /www/web/cusabio_cn/public_html/caches/caches_template/default/content/show_product_protein.php on line 662
Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.
復(fù)溶：

We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
儲(chǔ)存條件：

Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
保質(zhì)期：

The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
貨期：

Delivery time may differ from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.
注意事項(xiàng)：

Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Datasheet ：

Please contact us to get it.

產(chǎn)品評(píng)價(jià)

靶點(diǎn)詳情

功能：

Prevents the establishment of the cellular antiviral state by inhibiting TRIM25-mediated DDX58 ubiquitination, which normally triggers the antiviral transduction signal that leads to the activation of type I IFN genes by transcription factors IRF3 and IRF7. Prevents human EIF2AK2/PKR activation, either by binding double-strand RNA, or by interacting directly with EIF2AK2/PKR. This function may be important at the very beginning of the infection, when NS1 is mainly present in the cytoplasm. Also binds poly(A) and U6 snRNA.; Inhibits post-transcriptional processing of cellular pre-mRNA, by binding and inhibiting two cellular proteins that are required for the 3'-end processing of cellular pre-mRNAs: the 30 kDa cleavage and polyadenylation specificity factor/CPSF4 and the poly(A)-binding protein 2/PABPN1. In turn, unprocessed 3' end pre-mRNAs accumulate in the host nucleus and are no longer exported to the cytoplasm. Cellular protein synthesis is thereby shut off very early after virus infection. Viral protein synthesis is not affected by the inhibition of the cellular 3' end processing machinery because the poly(A) tails of viral mRNAs are produced by the viral polymerase through a stuttering mechanism.
基因功能參考文獻(xiàn)：
1. A recombinant pandemic H1N1 virus containing PA, PA-X, and NS1 genes from currently circulating viruses is fitter in replication in cultured cells and in mice and is slightly more pathogenic than the original ancestor pandemic H1N1 virus. PMID: 30021892
2. Results confirm that Influenza A virus (IAV) mutant lacking NS1 differs from wild-type in that it induces the production of readily detectable levels of Dicer-dependent viral siRNAs in infected human cells. However, data also demonstrate that these siRNAs have little if any inhibitory effect on IAV gene expression. This is likely due, at least in part, to their inefficient loading into RNA-induced silencing complexes. PMID: 29903832
3. Study found that the viral NS1 protein directly interacted with cellular Rac1 and facilitated viral replication. Further research revealed that NS1 down-regulated Rac1 activity via post-translational modifications. PMID: 27869202
4. NS1-mediated JNK activation and apoptosis induction are functionally independent from each other in vivo. PMID: 28076660
5. Mutations at position 171 in the NS1 protein result in decreased expression of IFN and ISGs by A549 cells. PMID: 28757142
6. Optimal control of host protein synthesis by Influenza A viruses (IAVs) PA-X and/or NS1 proteins is required for efficient IAV replication in the host. PMID: 28637750
7. The G45R mutation in the NS1 of H1N1 virus is critical for the enhanced viral replication in A549 cells. PMID: 27405392
8. NS1 facilitates late viral gene expression by acting as an adaptor between viral mRNAs and the cellular nuclear export machinery to promote their nuclear export. PMID: 28515301
9. data establish a model in which the Influenza A virus NS1 N-terminal domain engages in a binding interaction to inhibit activation of PKR and ensure efficient viral propagation and virulence PMID: 28250123
10. Influenza a virus NS1 has a role in inducing A20 contributes to viral replication by suppressing interferon-induced antiviral response PMID: 27914808
11. NF90 exerts its antiviral activity by antagonizing the inhibitory role of NS1 on PKR phosphorylation PMID: 27423063
12. this study shows that influenza virus upregulated CTHRC1 expression through its NS1 protein PMID: 27718266
13. Multifunctional NS1 protein is differentially phosphorylated throughout the replication cycle and that phospho-modification at threonine 49 acts as a molecular switch that alters NS1 activity. PMID: 26687707
14. The C terminus of NS1 protein of influenza H1N1 virus modulates antiviral responses in infected human macrophages. PMID: 25934792
15. These data show that RNase L targets specific sites in both host and viral RNAs to restrict influenza virus replication when NS1 protein is disabled. PMID: 25540362
16. Mutations in NS1 gene is associated with virulence. PMID: 24699508
17. Data show that 4 drug-like compounds from traditional Chinese Medicine (TCM) database were selected as potential inhibitors for the cleavage and polyadenylation specific factor CPSF30-binding site of influenza A virus of non-structural protein 1 (NS1A). PMID: 24562912
18. A mutant virus with deletion of NS1 induced high levels of IFN-I in control cells. PMID: 24899174
19. In experimentally infected chickens, the NS1del8084 virus showed both an increased replication potential and an increased pathogenicity. This in vivo phenotype was correlated with a higher replicative efficiency in vitro. PMID: 24694396
20. These results suggest that the PBM in the NS1 protein may determine viral persistence in the human and avian IAV interface. PMID: 24802398
21. hnRNP A2/B1 plays an inhibitory role in the replication of influenza A virus through suppressing NS1 RNA/protein levels and NS1 mRNA nucleocytoplasmic translocation. PMID: 24418537
22. Data indicate that strains of the 2009 H1N1 pandemic influenza A virus could be divided into two categories based on the V123I mutation in the NS1 gene G1 and G2. PMID: 23418535
23. This observation indicates the existence of an optimal level of NS1 SUMOylation that allows NS1 to achieve maximal activity. PMID: 23468495
24. The NS1 protein of influenza A virus interacts with cellular processing bodies and stress granules through RNA-associated protein 55 (RAP55) during virus infection. PMID: 22973032
25. NS1-W187R protein exhibited lower double-stranded RNA (dsRNA)-binding activity, showed a temporal redistribution during infection, and was minimally compromised for interferon antagonism. PMID: 22993153
26. Mutations in the M-gene segment can substantially increase replication efficiency of NS1 deletion influenza A virus in MDCK cells PMID: 22951840
27. Data show that infection of melanoma cells with delNS1-IL-15 resulted in the production of high levels of biologically active IL-15. PMID: 22563505
28. There are commonalities but also functional differences in the roles of NS1 and E3 as inhibitors of the innate antiviral response. PMID: 22174864
29. RNA helicase A as a cellular factor that interacts with influenza A virus NS1 protein and its role in the virus life cycle. PMID: 22171255
30. The C-terminal 11-aa truncation in NS1 did not significantly alter virus replication, but increased virus pathogenicity in mice. PMID: 22022552
31. Viral NS1-mediated delay of type I interferon induction contributes to influenza A virulence. PMID: 21411677
32. Results allowed visualization of NS1 protein nuclear import in virus-infected cells in real time. PMID: 20463066
33. The data obtained in this study demonstrate that the non-structural influenza A viral protein NS1A is an authentic SUMO target. PMID: 19917317
34. RIG-I is required for induction of IFN-I in an influenza A virus (IAV)-infected human lung epithelial cell line. PMID: 17053203
35. Our results indicate that, in addition to sequestering dsRNA, the NS1 of influenza A virus binds to RIG-I and inhibits downstream activation of IRF-3, preventing the transcriptional induction of IFN-beta. PMID: 17079289
36. Mutant viruses carrying NS1 with mutations in SH3 binding motif 1 failed to interact with p85ss and induce the subsequent activation of PI3K/Akt pathway. PMID: 17881440
37. These data suggest a model by which NS1 activates PI3K catalytic activity by masking a normal regulatory element specific to the p85beta inter-SH2 domain. PMID: 18029356
38. These results suggest that NS1-2 recognizes the U6 snRNA in a similar manner to NS1 protein. PMID: 18039687
39. Viral nonstructural protein 1 inhibits activation of RIG-I by binding to TRIM25. PMID: 19454344
40. NS1 inhibits TRIM25-mediated RIG-I ubiquitination, thereby suppressing RIG-I signal transduction. PMID: 19454348
41. influenza virus uses the NS1 protein to replicate for almost 2 days after infection before detection by the immune system. PMID: 19717515
42. Mutants of a highly virulent variant of A/PR/8/34 (H1N1) carrying either a complete deletion or C-terminal truncations of NS1 were far more potent inducers of IFN in infected mice than NS1 mutants derived from standard A/PR/8/34. PMID: 19726611
顯示更多

收起更多
亞細(xì)胞定位：

Host nucleus. Host cytoplasm.
蛋白家族：

Influenza A viruses NS1 family
數(shù)據(jù)庫(kù)鏈接：

KEGG: vg:956533